No government agency is permitted to approve Nyloxin unless they make a minor change in the formulation (homeopathy). That’s one of the reasons it was quickly removed from the GSA listing, likely never to return in its present form.
Also, to protect themselves from lawsuits, the gov requires high standards for acceptance of Nyloxin: double-blind, placebo-controlled, published and peer-reviewed. In spite of being an awesome product, none of Nyloxin’s studies meet those requirements.